Regulation of wound healing and organ fibrosis by toll-like receptors

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 7, 2013, Pages 1005-1017

  Huebener, Peter ^a   Schwabe, Robert F ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Fibrosis; Toll like receptor; Wound healing

Indexed keywords

CD14 ANTIGEN; COLLAGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

ALCOHOL ABUSE; CELL POPULATION; CELL TYPE; CYTOKINE PRODUCTION; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEPATITIS; HUMAN; LIVER FIBROSIS; LUNG FIBROSIS; MOLECULAR MECHANICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN FIBROSIS; WOUND HEALING; INFLAMMATION;

BACTERIA (MICROORGANISMS);

FIBROSIS; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; WOUND HEALING;

EID: 84877073295     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.11.017     Document Type: Review

References (229)

1. Kimbrell D.A., Beutler B. The evolution and genetics of innate immunity. Nat. Rev. Genet. 2001, 2:256-267.
2. Hoffmann J.A., Reichhart J.M. Drosophila innate immunity: an evolutionary perspective. Nat. Immunol. 2002, 3:121-126.
3. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
4. Luedde T., Schwabe R.F. Nf-Kappab in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:108-118.
5. Kluwe J., Mencin A., Schwabe R.F. Toll-like receptors, wound healing, and carcinogenesis. J. Mol. Med. (Berl.) 2009, 87:125-138.
6. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
7. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18:1028-1040.
8. Cunningham M.A., Romas P., Hutchinson P., Holdsworth S.R., Tipping P.G. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory in macrophages. Blood 1999, 94:3413-3420.
9. Johnson K., Choi Y., DeGroot E., Samuels I., Creasey A., Aarden L. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J. Immunol. 1998, 160:5130-5135.
10. Demetz G., Seitz I., Stein A., Steppich B., Groha P., Brandl R., Schomig A., Ott I. Tissue factor-factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. Atherosclerosis 2010, 212:466-471.
11. Scotton C.J., Krupiczojc M.A., Konigshoff M., Mercer P.F., Lee Y.C., Kaminski N., Morser J., Post J.M., Maher T.M., Nicholson A.G., Moffatt J.D., Laurent G.J., Derian C.K., Eickelberg O., Chambers R.C. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest. 2009, 119:2550-2563.
12. Steinhubl S.R. Platelets as mediators of inflammation. Hematol. Oncol. Clin. North Am. 2007, 21:115-121.
13. Dees C., Akhmetshina A., Zerr P., Reich N., Palumbo K., Horn A., Jungel A., Beyer C., Kronke G., Zwerina J., Reiter R., Alenina N., Maroteaux L., Gay S., Schett G., Distler O., Distler J.H. Platelet-derived serotonin links vascular disease and tissue fibrosis. J. Exp. Med. 2011, 208:961-972.
14. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., Heine U.I., Liotta L.A., Falanga V., Kehrl J.H., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4167-4171.
15. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
16. S, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
17. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
18. Discher D.E., Janmey P., Wang Y.L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
19. Wells R.G. The role of matrix stiffness in regulating cell behavior. Hepatology 2008, 47:1394-1400.
20. Olsen A.L., Bloomer S.A., Chan E.P., Gaca M.D., Georges P.C., Sackey B., Uemura M., Janmey P.A., Wells R.G. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G110-G118.
21. Ahrens S., Zelenay S., Sancho D., Hanc P., Kjaer S., Feest C., Fletcher G., Durkin C., Postigo A., Skehel M., Batista F., Thompson B., Way M., Reis e Sousa C., Schulz O. F-Actin is an evolutionarily conserved damage-associated molecular pattern recognized by Dngr-1, a receptor for dead cells. Immunity 2012, 36:635-645.
22. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 2007, 23:435-461.
23. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425:516-521.
24. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. Rage mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
25. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (Hmgb1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
26. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
27. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
28. Lotfi R., Eisenbacher J., Solgi G., Fuchs K., Yildiz T., Nienhaus C., Rojewski M.T., Schrezenmeier H. Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material. Eur. J. Immunol. 2011, 41:2021-2028.
29. Meran S., Thomas D., Stephens P., Martin J., Bowen T., Phillips A., Steadman R. Involvement of hyaluronan in regulation of fibroblast phenotype. J. Biol. Chem. 2007, 282:25687-25697.
30. Anderson K.V., Bokla L., Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the toll gene product. Cell 1985, 42:791-798.
31. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
32. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
33. Rutschmann S., Kilinc A., Ferrandon D. Cutting edge: the Toll pathway is required for resistance to gram-positive bacterial infections in Drosophila. J. Immunol. 2002, 168:1542-1546.
34. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54(Pt 1):1-13.
35. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCR mice: mutations in TLR4 gene. Science 1998, 282:2085-2088.
36. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001, 7:167-202.
37. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., Beutler B. Cd14 is required for Myd88-independent Lps signaling. Nat. Immunol. 2005, 6:565-570.
38. Han J.H., Akira S., Calame K., Beutler B., Selsing E., Imanishi-Kari T. Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity 2007, 27:64-75.
39. Beutler B. Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease. Immunol. Rev. 2007, 220:113-128.
40. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
41. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., Noble P.W. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11:1173-1179.
42. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., Noble P.W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. the role of HA size and CD44. J. Clin. Invest. 1996, 98:2403-2413.
43. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J., Powell J.D., Horton M.R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 2006, 177:1272-1281.
44. Noble P.W., Jiang D. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc. Am. Thorac. Soc. 2006, 3:401-404.
45. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. Hmgb1 and rage in inflammation and cancer. Annu. Rev. Immunol. 2010, 28:367-388.
46. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein Hmgb1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
47. Yu M., Wang H., Ding A., Golenbock D.T., Latz E., Czura C.J., Fenton M.J., Tracey K.J., Yang H. HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2. Shock 2006, 26:174-179.
48. Rouhiainen A., Tumova S., Valmu L., Kalkkinen N., Rauvala H. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant Hmgb1 (amphoterin). J. Leukoc. Biol. 2007, 81:49-58.
49. Youn J.H., Oh Y.J., Kim E.S., Choi J.E., Shin J.S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 2008, 180:5067-5074.
50. Hreggvidsdottir H.S., Lundberg A.M., Aveberger A.C., Klevenvall L., Andersson U., Harris H.E. High mobility group box protein 1 (Hmgb1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol. Med. 2012, 18:224-230.
51. Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., Nakasato M., Lu Y., Hangai S., Koshiba R., Savitsky D., Ronfani L., Akira S., Bianchi M.E., Honda K., Tamura T., Kodama T., Taniguchi T. Hmgb proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009, 462:99-103.
52. Venereau E., Casalgrandi M., Schiraldi M., Antoine D.J., Cattaneo A., De Marchis F., Liu J., Antonelli A., Preti A., Raeli L., Shams S.S., Yang H., Varani L., Andersson U., Tracey K.J., Bachi A., Uguccioni M., Bianchi M.E. Mutually exclusive redox forms of Hmgb1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 2012, 209(9):1519-1528.
53. Fan J., Frey R.S., Malik A.B. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 2003, 112:1234-1243.
54. Latz E., Golenbock D.T. Receptor "cross talk" in innate immunity. J. Clin. Invest. 2003, 112:1136-1137.
55. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
56. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
57. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
58. Honda K., Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 2006, 6:644-658.
59. O'Neill L.A. When signaling pathways collide: positive and negative regulation of Toll-Like receptor signal transduction. Immunity 2008, 29:12-20.
60. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
61. Bagchi A., Herrup E.A., Warren H.S., Trigilio J., Shin H.S., Valentine C., Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 2007, 178:1164-1171.
62. Grote K., Schutt H., Schieffer B. Toll-like receptors in angiogenesis. Sci. World J. 2011, 11:981-991.
63. Jagavelu K., Routray C., Shergill U., O'Hara S.P., Faubion W., Shah V.H. Endothelial cell Toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver. Hepatology 2010, 52:590-601.
64. Yang X., Coriolan D., Murthy V., Schultz K., Golenbock D.T., Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1069-H1076.
65. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117:524-529.
66. Dulauroy S., Di Carlo S.E., Langa F., Eberl G., Peduto L. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat. Med. 2012, 18:1262-1270.
67. Duffield J.S. The elusive source of myofibroblasts: problem solved?. Nat. Med. 2012, 18:1178-1180.
68. Pierer M., Rethage J., Seibl R., Lauener R., Brentano F., Wagner U., Hantzschel H., Michel B.A., Gay R.E., Gay S., Kyburz D. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 2004, 172:1256-1265.
69. Otte J.M., Rosenberg I.M., Podolsky D.K. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003, 124:1866-1878.
70. He Z., Zhu Y., Jiang H. Inhibiting Toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir. Res. 2009, 10:126.
71. He Z., Zhu Y., Jiang H. Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-Akt pathway in fibroblasts during acute lung injury. J. Recept. Signal Transduct. Res. 2009, 29:119-125.
72. Trujillo G., Meneghin A., Flaherty K.R., Sholl L.M., Myers J.L., Kazerooni E.A., Gross B.H., Oak S.R., Coelho A.L., Evanoff H., Day E., Toews G.B., Joshi A.D., Schaller M.A., Waters B., Jarai G., Westwick J., Kunkel S.L., Martinez F.J., Hogaboam C.M. TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci. Transl. Med. 2010, 2:57ra82.
73. Meneghin A., Choi E.S., Evanoff H.L., Kunkel S.L., Martinez F.J., Flaherty K.R., Toews G.B., Hogaboam C.M. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem. Cell Biol. 2008, 130:979-992.
74. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
75. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., Schwabe R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13:1324-1332.
76. Zhang Z., Lin C., Peng L., Ouyang Y., Cao Y., Wang J., Friedman S.L., Guo J. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells. Life Sci. 2012, 91(5-6):207-212.
77. Paik Y.H., Lee K.S., Lee H.J., Yang K.M., Lee S.J., Lee D.K., Han K.H., Chon C.Y., Lee S.I., Moon Y.M., Brenner D.A. Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab. Invest. 2006, 86:676-686.
78. Watanabe A., Hashmi A., Gomes D.A., Town T., Badou A., Flavell R.A., Mehal W.Z. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via Toll-like receptor 9. Hepatology 2007, 46:1509-1518.
79. Gabele E., Muhlbauer M., Dorn C., Weiss T.S., Froh M., Schnabl B., Wiest R., Scholmerich J., Obermeier F., Hellerbrand C. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem. Biophys. Res. Commun. 2008, 376:271-276.
80. Miura K., Kodama Y., Inokuchi S., Schnabl B., Aoyama T., Ohnishi H., Olefsky J.M., Brenner D.A., Seki E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 2010, 139:323-334. (e327).
81. De Minicis S., Seki E., Uchinami H., Kluwe J., Zhang Y., Brenner D.A., Schwabe R.F. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007, 132:1937-1946.
82. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E., Pollard J.W., Frampton J., Liu K.J., Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
83. Cumano A., Godin I. Ontogeny of the hematopoietic system. Annu. Rev. Immunol. 2007, 25:745-785.
84. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
85. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11:762-774.
86. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 2008, 26:421-452.
87. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
88. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
89. Fallowfield J.A., Mizuno M., Kendall T.J., Constandinou C.M., Benyon R.C., Duffield J.S., Iredale J.P. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 2007, 178:5288-5295.
90. Rivera C.A., Bradford B.U., Hunt K.J., Adachi Y., Schrum L.W., Koop D.R., Burchardt E.R., Rippe R.A., Thurman R.G. Attenuation of Ccl(4)-induced hepatic fibrosis by Gdcl(3) treatment or dietary glycine. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281:G200-G207.
91. Toyoda Y., Shida T., Wakita N., Matoba Y., Ozaki N. Mitral valve replacement in a patient with an extensively calcified mitral anulus: report of a case. Surg. Today 1998, 28:427-429.
92. Rivera C.A., Adegboyega P., van Rooijen N., Tagalicud A., Allman M., Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 2007, 47:571-579.
93. Diamond J.R., Pesek-Diamond I. Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. Am. J. Physiol. 1991, 260:F779-F786.
94. van Goor H., van der Horst M.L., Fidler V., Grond J. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab. Invest. 1992, 66:564-571.
95. Sung S.A., Jo S.K., Cho W.Y., Won N.H., Kim H.K. Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Exp. Nephrol. 2007, 105:e1-e9.
96. Machida Y., Kitamoto K., Izumi Y., Shiota M., Uchida J., Kira Y., Nakatani T., Miura K. Renal fibrosis in murine obstructive nephropathy is attenuated by depletion of monocyte lineage, not dendritic cells. J. Pharmacol. Sci. 2010, 114:464-473.
97. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol. 2009, 175:2454-2462.
98. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., Roers A., Eming S.A. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 2010, 184:3964-3977.
99. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
100. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
101. Megias J., Yanez A., Moriano S., O'Connor J.E., Gozalbo D., Gil M.L. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages. Stem Cells 2012, 30:1486-1495.
102. Salkowski C.A., Detore G., Franks A., Falk M.C., Vogel S.N. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid a prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 1998, 66:3569-3578.
103. Wang Z.M., Liu C., Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 2000, 275:20260-20267.
104. West A.P., Brodsky I.E., Rahner C., Woo D.K., Erdjument-Bromage H., Tempst P., Walsh M.C., Choi Y., Shadel G.S., Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
105. Sanjuan M.A., Dillon C.P., Tait S.W., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J.L., Withoff S., Green D.R. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
106. Prince L.R., Allen L., Jones E.C., Hellewell P.G., Dower S.K., Whyte M.K., Sabroe I. The role of interleukin-1beta in direct and Toll-like receptor 4-mediated neutrophil activation and survival. Am. J. Pathol. 2004, 165:1819-1826.
107. Walmsley S.R., Cowburn A.S., Sobolewski A., Murray J., Farahi N., Sabroe I., Chilvers E.R. Characterization of the survival effect of tumour necrosis factor-alpha in human neutrophils. Biochem. Soc. Trans. 2004, 32:456-460.
108. Meerschaert J., Busse W.W., Bertics P.J., Mosher D.F. Cd14(+) cells are necessary for increased survival of eosinophils in response to lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 2000, 23:780-787.
109. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 2010, 10:427-439.
110. Laskin D.L., Gardner C.R., Price V.F., Jollow D.J. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995, 21:1045-1050.
111. Koop D.R., Klopfenstein B., Iimuro Y., Thurman R.G. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of Cyp2e1. Mol. Pharmacol. 1997, 51:944-950.
112. Iimuro Y., Yamamoto M., Kohno H., Itakura J., Fujii H., Matsumoto Y. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats-analysis of mechanisms of lethality in endotoxemia. J. Leukoc. Biol. 1994, 55:723-728.
113. Zhao M., Fernandez L.G., Doctor A., Sharma A.K., Zarbock A., Tribble C.G., Kron I.L., Laubach V.E. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L1018-L1026.
114. Frank J.A., Wray C.M., McAuley D.F., Schwendener R., Matthay M.A. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L1191-L1198.
115. Prakash A., Mesa K.R., Wilhelmsen K., Xu F., Dodd O.J., Hellman J. Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice. Anesthesiology 2012, 117(4):822-835.
116. Pendino K.J., Meidhof T.M., Heck D.E., Laskin J.D., Laskin D.L. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am. J. Respir. Cell Mol. Biol. 1995, 13:125-132.
117. Day Y.J., Huang L., Ye H., Linden J., Okusa M.D. Renal ischemia-reperfusion injury and adenosine 2a receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. Renal Physiol. 2005, 288:F722-F731.
118. Lu L., Faubel S., He Z., Andres Hernando A., Jani A., Kedl R., Edelstein C.L. Depletion of macrophages and dendritic cells in ischemic acute kidney injury. Am. J. Nephrol. 2012, 35:181-190.
119. Carlos C.P., Mendes G.E., Miquelin A.R., Luz M.A., da Silva C.G., van Rooijen N., Coimbra T.M., Burdmann E.A. Macrophage depletion attenuates chronic cyclosporine A nephrotoxicity. Transplantation 2010, 89:1362-1370.
120. Duffield J.S., Tipping P.G., Kipari T., Cailhier J.F., Clay S., Lang R., Bonventre J.V., Hughes J. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am. J. Pathol. 2005, 167:1207-1219.
121. Hayashi F., Means T.K., Luster A.D. Toll-like receptors stimulate human neutrophil function. Blood 2003, 102:2660-2669.
122. Dick E.P., Prince L.R., Prestwich E.C., Renshaw S.A., Whyte M.K., Sabroe I. Pathways regulating lipopolysaccharide-induced neutrophil survival revealed by lentiviral transduction of primary human neutrophils. Immunology 2009, 127:249-255.
123. Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992, 80:2012-2020.
124. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 2003, 284:C870-C879.
125. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial damps cause inflammatory responses to injury. Nature 2010, 464:104-107.
126. Marques P.E., Amaral S.S., Pires D.A., Nogueira L.L., Soriani F.M., Freire Lima B.H., Oliveira Lopes G.A., Russo R.C., Avila T.V., Melgaco J.G., Oliveira A.G., Pinto M.A., Lima C.X., de Paula A.M., Cara D.C., Leite M.F., Teixeira M.M., Menezes G.B. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 2012, 56(5):1971-1982.
127. Zhang Q., Itagaki K., Hauser C.J. Mitochondrial DNA is released by shock and activates neutrophils via P38 map kinase. Shock 2010, 34:55-59.
128. Ryckman C., Vandal K., Rouleau P., Talbot M., Tessier P.A. Proinflammatory activities of S100: proteins S100a8, S100a9, and S100a8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 2003, 170:3233-3242.
129. McDonald B., Pittman K., Menezes G.B., Hirota S.A., Slaba I., Waterhouse C.C., Beck P.L., Muruve D.A., Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
130. Gujral J.S., Farhood A., Bajt M.L., Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003, 38:355-363.
131. Jaeschke H., Farhood A., Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 1990, 4:3355-3359.
132. Grommes J., Soehnlein O. Contribution of neutrophils to acute lung injury. Mol. Med. 2011, 17:293-307.
133. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995, 91:1872-1885.
134. Kelly K.J., Williams W.W., Colvin R.B., Meehan S.M., Springer T.A., Gutierrez-Ramos J.C., Bonventre J.V. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 1996, 97:1056-1063.
135. Dovi J.V., He L.K., DiPietro L.A. Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 2003, 73:448-455.
136. Martin P., D'Souza D., Martin J., Grose R., Cooper L., Maki R., McKercher S.R. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr. Biol. 2003, 13:1122-1128.
137. Chua F., Dunsmore S.E., Clingen P.H., Mutsaers S.E., Shapiro S.D., Segal A.W., Roes J., Laurent G.J. Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 2007, 170:65-74.
138. Takemasa A., Ishii Y., Fukuda T. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. Eur. Respir. J. 2012, 40(6):1475-1482.
139. Zaldivar M.M., Pauels K., von Hundelshausen P., Berres M.L., Schmitz P., Bornemann J., Kowalska M.A., Gassler N., Streetz K.L., Weiskirchen R., Trautwein C., Weber C., Wasmuth H.E. Cxc chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology 2010, 51:1345-1353.
140. Louis H., Van Laethem J.L., Wu W., Quertinmont E., Degraef C., Van den Berg K., Demols A., Goldman M., Le Moine O., Geerts A., Deviere J. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998, 28:1607-1615.
141. Saito J.M., Bostick M.K., Campe C.B., Xu J., Maher J.J. Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis. Hepatol. Res. 2003, 25:180-191.
142. Xu J., Lee G., Wang H., Vierling J.M., Maher J.J. Limited role for Cxc chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G734-G741.
143. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M., Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 1989, 83:865-875.
144. Rovere P., Peri G., Fazzini F., Bottazzi B., Doni A., Bondanza A., Zimmermann V.S., Garlanda C., Fascio U., Sabbadini M.G., Rugarli C., Mantovani A., Manfredi A.A. The long pentraxin Ptx3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 2000, 96:4300-4306.
145. C.Human Microbiome Project Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
146. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
147. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
148. Dapito D.H., Mencin A., Gwak G.Y., Pradere J.P., Jang M.K., Mederacke I., Caviglia J.M., Khiabanian H., Adeyemi A., Bataller R., Lefkowitch J.H., Bower M., Friedman R., Sartor R.B., Rabadan R., Schwabe R.F. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012, 21:504-516.
149. Macedo L., Pinhal-Enfield G., Alshits V., Elson G., Cronstein B.N., Leibovich S.J. Wound healing is impaired in Myd88-deficient mice: a role for Myd88 in the regulation of wound healing by adenosine A2a receptors. Am. J. Pathol. 2007, 171:1774-1788.
150. Lai Y., Di Nardo A., Nakatsuji T., Leichtle A., Yang Y., Cogen A.L., Wu Z.R., Hooper L.V., Schmidt R.R., von Aulock S., Radek K.A., Huang C.M., Ryan A.F., Gallo R.L. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 2009, 15:1377-1382.
151. Gasse P., Mary C., Guenon I., Noulin N., Charron S., Schnyder-Candrian S., Schnyder B., Akira S., Quesniaux V.F., Lagente V., Ryffel B., Couillin I. Il-1r1/Myd88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Invest. 2007, 117:3786-3799.
152. Kinnebrew M.A., Pamer E.G. Innate immune signaling in defense against intestinal microbes. Immunol. Rev. 2012, 245:113-131.
153. Gregorio J., Meller S., Conrad C., Di Nardo A., Homey B., Lauerma A., Arai N., Gallo R.L., Digiovanni J., Gilliet M. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 2010, 207:2921-2930.
154. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 2001, 167:1882-1885.
155. Abreu M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010, 10:131-144.
156. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
157. Schwabe R.F., Seki E., Brenner D.A. Toll-like receptor signaling in the liver. Gastroenterology 2006, 130:1886-1900.
158. Matsumura T., Degawa T., Takii T., Hayashi H., Okamoto T., Inoue J., Onozaki K. Traf6-Nf-Kappab pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 2003, 109:127-136.
159. Mimura Y., Sakisaka S., Harada M., Sata M., Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 1995, 109:1969-1976.
160. Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011, 6:425-456.
161. Triger D.R., Boyer T.D., Levin J. Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut 1978, 19:935-939.
162. Nolan J.P. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 2010, 52:1829-1835.
163. Wiest R., Garcia-Tsao G. Bacterial translocation (Bt) in cirrhosis. Hepatology 2005, 41:422-433.
164. Lin R.S., Lee F.Y., Lee S.D., Tsai Y.T., Lin H.C., Lu R.H., Hsu W.C., Huang C.C., Wang S.S., Lo K.J. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J. Hepatol. 1995, 22:165-172.
165. Fouts D.E., Torralba M., Nelson K.E., Brenner D.A., Schnabl B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J. Hepatol. 2012, 56:1283-1292.
166. Seki E., Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 2012, 590:447-458.
167. Rutenburg A.M., Sonnenblick E., Koven I., Aprahamian H.A., Reiner L., Fine J. The role of intestinal bacteria in the development of dietary cirrhosis in rats. J. Exp. Med. 1957, 106:1-14.
168. Broitman S.A., Gottlieb L.S., Zamcheck N. Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat. J. Exp. Med. 1964, 119:633-642.
169. Zhu Q., Zou L., Jagavelu K., Simonetto D.A., Huebert R.C., Jiang Z.D., DuPont H.L., Shah V.H. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J. Hepatol. 2012, 56:893-899.
170. -/- mice: involvement of Lps and TLR4. Hepatology 2009, 50:819A.
171. Gabele E., Dostert K., Hofmann C., Wiest R., Scholmerich J., Hellerbrand C., Obermeier F. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J. Hepatol. 2011, 55:1391-1399.
172. Yoneda M., Izawa K., Hirooka A., Hayashida K., Wakitani S. Indicators of superior glenoid labral detachment on magnetic resonance imaging and computed tomography arthrography. J. Shoulder Elbow Surg. 1998, 7:2-12.
173. Ni H., Nitta M., Komatsu H., Kojima S., Suzuki S., Harada S., Tsuboi K., Banno S., Wakita A., Yazaki M., Ren L., Kato T., Ueda R. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia. Cancer Lett. 1998, 124:173-180.
174. Isayama F., Hines I.N., Kremer M., Milton R.J., Byrd C.L., Perry A.W., McKim S.E., Parsons C., Rippe R.A., Wheeler M.D. Lps signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1318-G1328.
175. Wakita H., Matsushita K., Nishimura K., Tokura Y., Furukawa F., Takigawa M. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J. Invest. Dermatol. 1998, 110:253-258.
176. Paik Y.H., Schwabe R.F., Bataller R., Russo M.P., Jobin C., Brenner D.A. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003, 37:1043-1055.
177. Huang H., Shiffman M.L., Friedman S., Venkatesh R., Bzowej N., Abar O.T., Rowland C.M., Catanese J.J., Leong D.U., Sninsky J.J., Layden T.J., Wright T.L., White T., Cheung R.C. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007, 46:297-306.
178. Li Y., Chang M., Abar O., Garcia V., Rowland C., Catanese J., Ross D., Broder S., Shiffman M., Cheung R., Wright T., Friedman S.L., Sninsky J. Multiple variants in Toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J. Hepatol. 2009, 51:750-757.
179. Martin-Murphy B.V., Holt M.P., Ju C. The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. Toxicol. Lett. 2010, 192:387-394.
180. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., Yang H., Li J., Tracey K.J., Geller D.A., Billiar T.R. The nuclear factor Hmgb1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 2005, 201:1135-1143.
181. Wynn T.A. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 2011, 208:1339-1350.
182. Imaeda A.B., Watanabe A., Sohail M.A., Mahmood S., Mohamadnejad M., Sutterwala F.S., Flavell R.A., Mehal W.Z. Acetaminophen-induced hepatotoxicity in mice is dependent on TLR9 and the Nalp3 inflammasome. J. Clin. Invest. 2009, 119:305-314.
183. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., Stevenson M.A., Calderwood S.K. Novel signal transduction pathway utilized by extracellular Hsp70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002, 277:15028-15034.
184. Song J.Y., Li L., Ahn J.B., Park J.G., Jo J.S., Park D.H., Jang H.K., Jang J.J., Lee M.J. Acute liver toxicity by carbon tetrachloride in Hsp70 knockout mice. Exp. Toxicol. Pathol. 2007, 59:29-34.
185. Bamboat Z.M., Balachandran V.P., Ocuin L.M., Obaid H., Plitas G., DeMatteo R.P. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010, 51:621-632.
186. Xu J., Zhang X., Monestier M., Esmon N.L., Esmon C.T. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J. Immunol. 2011, 187:2626-2631.
187. Szabo G., Velayudham A., Romics L., Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of Toll-like receptors 2 and 4. Alcohol. Clin. Exp. Res. 2005, 29:140S-145S.
188. Rivera C.A., Gaskin L., Allman M., Pang J., Brady K., Adegboyega P., Pruitt K. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis. BMC Gastroenterol. 2010, 10:52.
189. Hartmann P., Haimerl M., Mazagova M., Brenner D.A., Schnabl B. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology 2012, 143(5):1330-1340. e1.
190. Bility M.T., Zhang L., Washburn M.L., Curtis T.A., Kovalev G.I., Su L. Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis. Nat. Protoc. 2012, 7:1608-1617.
191. -/- mice. Nat. Biotechnol. 2007, 25:903-910.
192. Pradere J.P., Troeger J.S., Dapito D.H., Mencin A.A., Schwabe R.F. Toll-like receptor 4 and hepatic fibrogenesis. Semin. Liver Dis. 2010, 30:232-244.
193. Kalambokis G.N., Tsianos E.V. Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis. Hepatology 2012, 55:655-656.
194. Kalambokis G.N., Mouzaki A., Rodi M., Tsianos E.V. Rifaximin for the prevention of spontaneous bacterial peritonitis. World J. Gastroenterol. 2012, 18:1700-1702.
195. Velayudham A., Dolganiuc A., Ellis M., Petrasek J., Kodys K., Mandrekar P., Szabo G. Vsl#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009, 49:989-997.
196. Beck J.M., Young V.B., Huffnagle G.B. The microbiome of the lung. Transl. Res. 2012, 160(4):258-266.
197. Zhao H., Leu S.W., Shi L., Dedaj R., Zhao G., Garg H.G., Shen L., Lien E., Fitzgerald K.A., Shiedlin A., Shen H., Quinn D.A., Hales C.A. TLR4 is a negative regulator in noninfectious lung inflammation. J. Immunol. 2010, 184:5308-5314.
198. Yang H.Z., Wang J.P., Mi S., Liu H.Z., Cui B., Yan H.M., Yan J., Li Z., Liu H., Hua F., Lu W., Hu Z.W. TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. Am. J. Pathol. 2012, 180:275-292.
199. Paun A., Fox J., Balloy V., Chignard M., Qureshi S.T., Haston C.K. Combined TLR2 and TLR4 deficiency increases radiation-induced pulmonary fibrosis in mice. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77:1198-1205.
200. Brickey W.J., Neuringer I.P., Walton W., Hua X., Wang E.Y., Jha S., Sempowski G.D., Yang X., Kirby S.L., Tilley S.L., Ting J.P. Myd88 provides a protective role in long-term radiation-induced lung injury. Int. J. Radiat. Biol. 2012, 88:335-347.
201. Gasse P., Riteau N., Charron S., Girre S., Fick L., Petrilli V., Tschopp J., Lagente V., Quesniaux V.F., Ryffel B., Couillin I. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 2009, 179:903-913.
202. Doz E., Noulin N., Boichot E., Guenon I., Fick L., Le Bert M., Lagente V., Ryffel B., Schnyder B., Quesniaux V.F., Couillin I. Cigarette smoke-induced pulmonary inflammation is TLR4/Myd88 and Il-1r1/Myd88 signaling dependent. J. Immunol. 2008, 180:1169-1178.
203. Wu H., Ma J., Wang P., Corpuz T.M., Panchapakesan U., Wyburn K.R., Chadban S.J. HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 2010, 21:1878-1890.
204. Wu H., Chen G., Wyburn K.R., Yin J., Bertolino P., Eris J.M., Alexander S.I., Sharland A.F., Chadban S.J. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 2007, 117:2847-2859.
205. Oyama Y., Hashiguchi T., Taniguchi N., Tancharoen S., Uchimura T., Biswas K.K., Kawahara K., Nitanda T., Umekita Y., Lotz M., Maruyama I. High-mobility group box-1 protein promotes granulomatous nephritis in nephropathy. Lab. Invest. 2010, 90:853-866.
206. Sato F., Maruyama S., Hayashi H., Sakamoto I., Yamada S., Uchimura T., Morita Y., Ito Y., Yuzawa Y., Maruyama I., Matsuo S. High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin. Pract. 2008, 108:c194-c201.
207. Rosin D.L., Okusa M.D. Dangers within: damp responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 2011, 22:416-425.
208. Saemann M.D., Weichhart T., Zeyda M., Staffler G., Schunn M., Stuhlmeier K.M., Sobanov Y., Stulnig T.M., Akira S., von Gabain A., von Ahsen U., Horl W.H., Zlabinger G.J. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J. Clin. Invest. 2005, 115:468-475.
209. Leemans J.C., Stokman G., Claessen N., Rouschop K.M., Teske G.J., Kirschning C.J., Akira S., van der Poll T., Weening J.J., Florquin S. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 2005, 115:2894-2903.
210. Shigeoka A.A., Holscher T.D., King A.J., Hall F.W., Kiosses W.B., Tobias P.S., Mackman N., McKay D.B. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both Myd88-dependent and -independent pathways. J. Immunol. 2007, 178:6252-6258.
211. Cunningham P.N., Wang Y., Guo R., He G., Quigg R.J. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J. Immunol. 2004, 172:2629-2635.
212. Zhang B., Ramesh G., Uematsu S., Akira S., Reeves W.B. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J. Am. Soc. Nephrol. 2008, 19:923-932.
213. Pulskens W.P., Rampanelli E., Teske G.J., Butter L.M., Claessen N., Luirink I.K., van der Poll T., Florquin S., Leemans J.C. TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J. Am. Soc. Nephrol. 2010, 21:1299-1308.
214. Campbell M.T., Hile K.L., Zhang H., Asanuma H., Vanderbrink B.A., Rink R.R., Meldrum K.K. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J. Surg. Res. 2011, 168:e61-e69.
215. Chowdhury P., Sacks S.H., Sheerin N.S. Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephron Exp. Nephrol. 2010, 115:e122-e130.
216. Leemans J.C., Butter L.M., Pulskens W.P., Teske G.J., Claessen N., van der Poll T., Florquin S. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 2009, 4:e5704.
217. Braga T.T., Correa-Costa M., Guise Y.F., Castoldi A., De Oliveira C.D., Hyane M.I., Cenedeze M.A., Teixeira S.A., Muscara M.N., Perez K.R., Cuccovia I.M., Pacheco-Silva A., Goncalves G.M., Camara N.O. Myd88 signaling pathway is involved in renal fibrosis by favoring a Th2 immune response and activating alternative M2 macrophages. Mol. Med. 2012, 18(1):1231-1239.
218. Skuginna V., Lech M., Allam R., Ryu M., Clauss S., Susanti H.E., Rommele C., Garlanda C., Mantovani A., Anders H.J. Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. PLoS One 2011, 6:e19204.
219. Lin Q., Wang L., Lin Y., Liu X., Ren X., Wen S., Du X., Lu T., Su S.Y., Yang X., Huang W., Zhou S., Wen F., Su S.B. Toll-like receptor 3 ligand polyinosinic:polycytidylic acid promotes wound healing in human and murine skin. J. Invest. Dermatol. 2012, 132:2085-2092.
220. Sato T., Yamamoto M., Shimosato T., Klinman D.M. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen. 2010, 18:586-593.
221. Yamamoto M., Sato T., Beren J., Verthelyi D., Klinman D.M. The acceleration of wound healing in primates by the local administration of immunostimulatory Cpg oligonucleotides. Biomaterials 2011, 32:4238-4242.
222. Wang J., Hori K., Ding J., Huang Y., Kwan P., Ladak A., Tredget E.E. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J. Cell. Physiol. 2011, 226:1265-1273.
223. Farina G.A., York M.R., Di Marzio M., Collins C.A., Meller S., Homey B., Rifkin I.R., Marshak-Rothstein A., Radstake T.R., Lafyatis R. Poly(I:C) drives type I Ifn- and Tgfbeta-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis. J. Invest. Dermatol. 2010, 130:2583-2593.
224. Shishido T., Nozaki N., Yamaguchi S., Shibata Y., Nitobe J., Miyamoto T., Takahashi H., Arimoto T., Maeda K., Yamakawa M., Takeuchi O., Akira S., Takeishi Y., Kubota I. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003, 108:2905-2910.
225. Mersmann J., Habeck K., Latsch K., Zimmermann R., Jacoby C., Fischer J.W., Hartmann C., Schrader J., Kirschning C.J., Zacharowski K. Left ventricular dilation in Toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation. Basic Res. Cardiol. 2011, 106:89-98.
226. Riad A., Jager S., Sobirey M., Escher F., Yaulema-Riss A., Westermann D., Karatas A., Heimesaat M.M., Bereswill S., Dragun D., Pauschinger M., Schultheiss H.P., Tschope C. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 2008, 180:6954-6961.
227. Timmers L., Sluijter J.P., van Keulen J.K., Hoefer I.E., Nederhoff M.G., Goumans M.J., Doevendans P.A., van Echteld C.J., Joles J.A., Quax P.H., Piek J.J., Pasterkamp G., de Kleijn D.P. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ. Res. 2008, 102:257-264.
228. Blyszczuk P., Kania G., Dieterle T., Marty R.R., Valaperti A., Berthonneche C., Pedrazzini T., Berger C.T., Dirnhofer S., Matter C.M., Penninger J.M., Luscher T.F., Eriksson U. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ. Res. 2009, 105:912-920.
229. Ha T., Hua F., Li Y., Ma J., Gao X., Kelley J., Zhao A., Haddad G.E., Williams D.L., Browder I.W., Kao R.L., Li C. Blockade of Myd88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H985-H994.